Abstract
Earlier functional studies on endogenous kinin formation in human plasma suggested that depending on the mode of treatment of the plasma, different kininogenases are activated predominantly: kininogenase I, activated by e.g. acid or acetone, acting on kininogen I; kininogenase II, activated by contact of plasma with glass, quartz etc., acting on kininogen II (Vogt, 1966). The existance of two kininogens, differing in molecular weight and affinity to plasma kallikrein, has meanwhile been well established. Kininogen II, highly sensitive to contact activated kininogenase(s), can be equated with high molecular weight kininogen (HMW-K), whereas kininogen I corresponds to low molecular weight kininogen (LMW-K) (Habal and Movat, 1972; Seidel, 1973; Habal et al., 1974). The existence of two kininogenases has been questioned however, since by fractionation of plasma other investigators found only one kinin-forming enzyme, plasma kallikrein — apart from the weakly active plasmin. Wendel et al. (1972) purified the contact-activated kininogenase (II) and found that it was not distinguishable in molecular size and isoelectric point from plasma kallikrein. The enzyme acted predominantly but not exclusively, on HMW-K (kininogen II). An attempt was therefore made to purify the acetone-activated enzyme (kininogenase I by the original definition) and to see whether it differs in its properties from the contact-activated enzyme.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bagdasarian, A., Lahiri, B., Talamo, R.C., Wong, P., Colman, R.W.: Immunochemical studies of plasma kallikrein. J.Clin.Invest. 54, 1444 (1974).
Habal, F.M., Movat, H.Z.: Kininogens of human plasma. Res. Comm. Chem. Path. Pharmacol. 4, 477 (1972).
Habal, F.M., Movat, H.Z., Burrowed, C.E.: Isolation of two functionally different kininogens from human plasma — Separation from proteinase inhibitors and interaction with plasma kalli-krein. Biochem. Pharmacol. 23, 2291 (1974).
Harpel, P.C.: Human plasma α2-macroglobulin. An inhibitor of plasma kallikrein. J. exp. Med. 132, 329 (1970).
McConnell, D.J.: Inhibitors of kallikrein in human plasma. J. Clin. Invest. 51, 1611 (1972).
Seidel, G: Two functionally different kininogens in human plasma. Agents and Actions 3, 12 (1973).
Vogt, W.: Demonstration of the presence of two separate kinin-forming systems in human and other plasma. In: Hypotensive peptides, p. 185, ed. by E.G. Erdos, N. Back and F. Sicuteri, Berlin-Heidelberg-New York: Springer 1966.
Wendel, U., Vogt, W., Seidel, G.: Purification and some properties of a kininogenase from human plasma activated by surface contact. Hoppe-Seylers Z. physiol. Chem. 353, 1591 (1972).
Wuepper, K.D.: Biochemistry and biology of components of the plasma kinin-forming system. In: Inflammation mechanism and control, p. 93, ed. by I.H. Lepow and P.A. Ward. Academic Press, New York, 1972.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Vogt, W. (1976). An Active Kallikrein-α2-Macroglobulin Complex Generated by Treatment of Human Plasma with Acetone. In: Sicuteri, F., Back, N., Haberland, G.L. (eds) Kinins. Advances in Experimental Medicine and Biology, vol 70. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3267-1_34
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3267-1_34
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3269-5
Online ISBN: 978-1-4684-3267-1
eBook Packages: Springer Book Archive